I remain deeply concerned with the prevalence of sexual assault and sexual harassment at the U.S. Merchant Marine Academy.

No responsiveness. No transparency. No accountability. It is really frightening and frustrating.

They trust the food they buy from the grocery store is safe.

Do you commit to making decisions on safety and efficacy of new products based on the standards in the current law and the science, and not bow to political pressure from the Administration?

Thank you for your past work to review efforts by the U.S. Merchant Marine Academy to address their ongoing issues with sexual assault and sexual harassment.

I have repeatedly stressed--privately and publicly--the importance of a thorough and complete vetting process for each of President Trump's nominees.

Disappointingly, Secretary Price failed to respond to a single one of the questions this committee asked him following his confirmation hearing.

I ask that you expand your review to encompass the entirety of the recently completed Culture Audit and the Academy's Action Plan.

Your commitment to make sure that any decision is science-based, evidence-based is really important on this issue to me.

Sexual assault is a heinous crime that must be eradicated in every corner of our society.

The crisis at the academy was highlighted in June 2016 when former Transportation Secretary Foxx temporarily suspended the Sea Year program.

I am very fearful that they will put political pressure on you to make decisions not based on science and not based on evidence-based treatment.

To date, five companies that have met these requirements are able to once again provide the necessary training to midshipmen on their vessels in a safe, zero-tolerance environment.

I strongly support policies that promote investment in research and development.

I am glad we are able to move forward with today's important discussion without the dark cloud of Trumpcare looming over us, at least for now.

The issue before us today, the FDA user fee reauthorizations, is a chief example of how we can work together to help patients and families.

I think it's really important that we all remember in this process that we've got to put patients and families first.

I've made it a priority to make sure women and minorities and older Americans are included in clinical trials.

We've got to do more to reign in costs.

I'm very glad that Trumpcare was soundly rejected and that more and more Republicans are finally accepting what so many of us have been saying for years.

I hear from patients and families and doctors and hospitals and businesses in my home State of Washington all the time about the astronomical cost of drugs.

It's really unacceptable not to know how these products actually work on the patients who need them.

Millions of families spoke out clearly about how Trumpcare would have been an absolute disaster for them.

Given that wealth of policy experience, we believe he will provide a steady hand at the FDA.

I want Senate Republicans who are about to take this vote--and Vice President Pence--to be very clear on what they are about to do. As a direct result of their choices today, extreme politicians in States across the country will have…